FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 23728354 · Received December 5, 2025

Report

Report Number
1823260-2025-04954
Event Type
Malfunction
Date Received
December 5, 2025
Date of Event
November 4, 2025
Report Date
January 13, 2026
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FIELD SERVICE ENGINEER FOUND AN ISSUE WITH A SOLENOID VALVE, WHICH LED TO INCOMPLETE ASPIRATION DURING THE CELL RINSE PROCESS. THE VALVE WAS REPLACED, AND CELL RINSE VOLUME ADJUSTMENTS AND MECHANICAL CHECKS WERE PERFORMED. THE SYSTEM PERFORMANCE WAS VERIFIED THROUGH A CELL BLANK MEASUREMENT AND QC THAT WERE ACCEPTABLE. THE INVESTIGAITON DETERMINED THAT THE SERVICE ACTIONS RESOLVED THE ISSUE.

Additional Manufacturer Narrative · 0

THE CHOLESTEROL REAGENT LOT NUMBER WAS 900693 WITH AN EXPIRATION DATE OF 31-MAY-2026. THE HDL-CHOLESTEROL REAGENT LOT NUMBER WAS 858795 WITH AN EXPIRATION DATE OF 31-JAN-2027. THE TOTAL PROTEIN REAGENT LOT NUMBER WAS 883217 WITH AN EXPIRATION DATE OF 31-AUG-2026. THE QC WAS ACCEPTABLE. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT SAMPLE TESTED WITH CHOLESTEROL GEN.2 ASSAY, HDL-CHOLESTEROL GEN.4 ASSAY, AND TOTAL PROTEIN GEN.2 ASSAY ON A COBAS C 503 ANALYTICAL UNIT. CHOLESTEROL: INITIAL RESULT: 46 MG/L. REPEAT RESULT: 241 MG/L. HDL-CHOLESTEROL: INITIAL RESULT: 24 MG/L. REPEAT RESULT: 46 MG/L. TOTAL PROTEIN: INITIAL RESULT: 30 G/DL. REPEAT RESULT: 6.3 G/DL. THE PROVIDER'S OFFICE QUESTIONED THE INITIAL RESULTS, PROMPTING THE REPEAT OF THE SAMPLE. THE REPEAT RESULTS WERE DEEMED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
494631 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 71 YR Female